City

Philadelphia (2)

Bethesda (1)

New York (1)

Condition

Astrocytoma (2)

Glioma (2)

Oligodendroglioma (2)

Anaplastic Astrocytoma (1)

Glioblastoma Multiforme (1)

IDH Mutation (1)

Overall Status

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Stephen Bagley, MD, MSCE (1)

Collaborator

Incyte Corporation (1)

University of Pennsylvania (1)

Intervention

all-trans retinoic acid (1)

retifanlimab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

Oligodendroglioma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting

Glioma
+3 more

Retifanlimab
All-trans retinoic acid

Philadelphia, Pennsylvania

University of Pennsylvania

Jul 22, 2022

Genetic Analysis of Brain Tumors

Terminated

Glioma
+4 more

Bethesda, Maryland
+2 more

Dec 6, 2019